TOXIC SHOCK SYNDROME

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 862-884

  Suen, Jeffrey ^a,b   Chesney, P Joan ^c,d,e   Davis, Jeffrey P ^f,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d LE BONHEUR CHILDREN S HOSPITAL   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149391148     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50076-5     Document Type: Chapter

References (341)

1. F.W. Abdul-Karim, M.M. Lederman, J.R. Carter, et al. (1981) Toxic shock syndrome: Clinicopathologic findings in a fatal case. Hum. Pathol. 12 16-22.
2. A.C. Abram, K.T. Bellian, W.J. Giles, et al. (1994) Toxic shock syndrome after functional endonasal sinus surgery: An all or none phenomenon? Laryngoscope 104 927-931.
3. S.T. Allen, J.B. Liland, C.G. Nichols, et al. (1990) Toxic shock syndrome associated with use of latex nasal packing. Arch. Intern. Med. 150 2587-2588.
4. H. Alsoub (1994) Toxic shock syndrome associated with pyomyositis. Postgrad. Med. J. 70 309-312.
5. Andrews, M. M., Giacobbe, K. D., and Parsonnet, J.: Induction of toxic shock syndrome toxin-1 (TSST-1) and beta-lactamase by subinhibitory concentrations of beta-lactam antibiotics. Abstract N-IN-0011. Presented at Biomedicine '96, May 3-6, 1996, Washington, DC.
6. M.M. Andrews, E.M. Parent, M. Barry and J. Parsonnet (2001) Recurrent nonmenstrual toxic shock syndrome: Clinical manifestations, diagnosis, and treatment. Clin. Infect. Dis. 32 1470-1479.
7. H. Aranow Jr. and W.B. Wood Jr. (1942) Staphylococcic infection simulating scarlet fever. J. A. M. A. 119 1491-1495.
8. S.M. Arend, A.V. Steenmeyer, P.C.M. Mosmans, et al. (1993) Postoperative cauda syndrome caused by Staphylococcus aureus. Infection 21 248-250.
9. P.M. Arnow, T. Chou, D. Weil, et al. (1984) Spread of a toxic-shock syndrome–associated strain of Staphylococcus aureus and measurement of antibodies to staphylococcal enterotoxin F. J. Infect. Dis. 149 103-107.
10. M.C. Bach (1983) Dermatologic signs in toxic shock syndrome: Clues to diagnosis. J. Am. Acad. Dermatol. 8 343-347.
11. E.A. Bacha, R.L. Sheridan, G.A. Donohue, et al. (1994) Staphylococcal toxic shock syndrome in a paediatric burn unit. Burns 20 499-502.
12. N. Balaban and R.P. Novick (1995) Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 92 1619-1623.
13. B. Bannister and A.J. Platts (1981) Some cardiological findings in toxic shock syndrome. J. Infect. 3 293-294.
14. V. Baracos, P. Rodemann, C.A. Dinarello, et al. (1983) Stimulation of muscle protein degradation and prostaglandin E 2 release by leucocytic pyrogen (interleukin-1). N. Engl. J. Med. 308 553-558.
15. J.A. Barrett and D.R. Graham (1986) TSS presenting as encephalopathy. J. Infect. 12 276.
16. W. Barry, L. Hudgins, S.T. Donta, et al. (1992) Intravenous immunoglobulin therapy for toxic-shock syndrome. J. A. M. A. 267 3315-3317.
17. P. Bartlett, A.L. Reingold, D.R. Graham, et al. (1982) Toxic shock syndrome associated with surgical wound infections. J. A. M. A. 247 1448-1450.
18. M. Batisson, N. Strazielle, M. Hejmadi, et al. (2006) Toxic shock syndrome toxin-1 challenges the neuroprotective functions of the choroidal epithelium and induces neurotoxicity. J. Infect. Dis. 194 341-349.
19. K. Becker, R. Roth and G. Peters (1998) Rapid and specific detection of toxigenic Staphylococcus aureus: Use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J. Clin. Microbiol. 36 2548-2553.
20. D.H. Beezhold, G.K. Best, P.F. Bonventre, et al. (1989) Endotoxin enhancement of TSST-1–induced secretion of interleukin-1 by murine macrophages. Rev. Infect. Dis. 11(Suppl.), 289-293.
21. W.R. Beisel (1972) Pathophysiology of staphylococcal enterotoxin, type B, (SEB) toxemia after the intravenous administration to monkeys. Toxicon 10 433.
22. M.S. Bergdoll and P.J. Chesney (1991) Toxic-Shock Syndrome Boca Raton, FL: CRC Press
23. M.S. Bergdoll, B.A. Crass, R.F. Reiser, et al. (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock syndrome Staphylococcus aureus isolates. Lancet 1 1017-1021.
24. S.F. Berkley, A.W. Hightower, C.W. Broome, et al. (1987) The relationship of tampon characteristics to menstrual toxic-shock syndrome. J. A. M. A. 258 917-920.
25. A.C. Berman and L.R. Boly (1991) Cisplatin therapy–associated recurrent toxic shock syndrome. West. J. Med. 155 415-416.
26. G.M. Bernstein, J.S. Crollick and J.M. Hassett Jr. (1988) Post febrile telogen effluvium in critically ill patients. Crit. Care Med. 16 98-99.
27. D.A. Black and D.S. Maw (1984) Toxic shock syndrome presenting as cerebral infarct. Corres. J. Neurol. Neurosurg. Psychiatry 47 568.
28. J.D. Blair, D.G. Livingston and R. Vongsnichakul (1982) Tampon-related toxic-shock syndrome: Histopathologic and clinical findings in a fatal case. Am. J. Clin. Pathol. 78 372-376.
29. G.A. Bohach, M.M. Dinges, D.T. Mitchell, et al. (1997) Staphylococcal exotoxins. D.Y.M. Leung, B.T. Huber, P.M. Schlievert (Eds) Superantigens: Molecular Biology, Immunology and Relevance to Human Disease New York: Marcel Dekker
30. R.C. Bone (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115 457-469.
31. P.F. Bonventre, H. Heeg, C. Cullen, et al. (1993) Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 61 793-799.
32. P.F. Bonventre, H. Heeg, C.K. Edwards III, et al. (1995) A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect. Immun. 63 509-515.
33. P.F. Bonventre, C. Linnemann, L.S. Weckback, et al. (1984) Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J. Infect. Dis. 150 662-666.
34. P.F. Bonventre, M.R. Thompson, L.E. Adinolfi, et al. (1987) Neutralization of TSST-1 by monoclonal antibodies in vitro and in vivo. Infect. Immun. 50 135.
35. S.D. Breda, J.B. Jacobs, A.S. Lebowitz, et al. (1987) Toxic shock syndrome in nasal surgery: A physiochemical and microbiologic evaluation of Merocel and NuGauze nasal packing. Laryngoscope 97 1388.
36. H. Brody and L.W. Smith (1936) The visceral pathology in scarlet fever and related Streptococcus infections. Am. J. Pathol. 12 373.
37. M.G. Brook and B.A. Bannister (1991) Staphylococcal enterotoxins in scarlet fever complicating chicken pox. Postgrad. Med. J. 67 1013-1014.
38. C.V. Broome (1989) Epidemiology of TSS in the United States: Overview. Rev. Infect. Dis. 11(Suppl.), 14-21.
39. E.J. Brown (2004) The molecular basis of streptococcal toxic shock syndrome. N. Engl. J. Med. 350 2093-2094.
40. Brown-Skrobot, S. K., Irving, M. M., and Wojnarowicz, L.: Tampon additives and toxic shock syndrome toxin-1 (TSST-1) production. Abstract B18. Presented at the 91st General Meeting of the American Society of Microbiology, 1991, Chicago, p. 28.
41. J.R. Burns and F.J. Menpace (1982) Acute reversible cardiomyopathy complicating toxic shock syndrome. Arch. Intern. Med. 142 1032-1034.
42. D.K. Cavanah and Z.K. Ballas (1993) Pseudoephedrine reaction presenting as recurrent toxic shock syndrome. Ann. Intern. Med. 119 302-303.
43. J.P. Cederna (1995) Toxic shock syndrome after transverse rectus abdominis musculocutaneous flap breast reconstruction. Ann. Plast. Surg. 34 73-75.
44. A.H. Chang, J.M. Musser and A.W. Chow (1991) A single clone which produces both TSST-1 and SEA causes the majority of menstrual toxic shock syndrome. Abstract. Clin. Res. 39 36.
45. T. Chatila and R.S. Geha (1993) Signal transduction by microbial superantigens via MHC class II molecules. Immunol. Rev. 131 43-59.
46. P.J. Chesney, B.A. Crass, M.B. Polyak, et al. (1982) Toxic-shock syndrome: Management and long-term sequelae. Ann. Intern. Med. 96 847-851.
47. P.J. Chesney, J.P. Davis, W.K. Purdy, et al. (1981) The clinical manifestations of toxic shock syndrome. J. A. M. A. 246 741-748.
48. P.J. Chesney, S.L. Slama, R.L. Hawkins, et al. (1981) Outpatient diagnosis and management of toxic-shock syndrome. N. Engl. J. Med. 304 1426.
49. P.J. Chesney and J.J. Zimmerman (1986) Hypoferrinemia in toxic-shock syndrome (TSS). Abstract. Pediatr. Res. 20 306.
50. R.W. Chesney, P.J. Chesney, J.P. Davis, et al. (1981) Renal manifestations of the staphylococcal toxic-shock syndrome. Am. J. Med. 71 583-588.
51. R.W. Chesney, D.M. McCarren, J.G. Haddad, et al. (1983) Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J. Lab. Clin. Med. 101 576-585.
52. C. Childs, V. Edwards-Jones, D.M. Healthcote, et al. (1994) Patterns of Staphylococcal aureus colonization, toxin production, immunity and illness in burned children. Burns 20 514-521.
53. Y. Choi, B. Kotzin, L. Herron, et al. (1989) Interaction of Staphylococcus aureus toxin “superantigens” with human T cells. Proc. Natl. Acad. Sci. U. S. A. 86 8941-8945.
54. Y. Choi, J.A. Lafferty, J.R. Clements, et al. (1990) Selective expansion of T cells expressing V beta 2 in toxic-shock syndrome. J. Exp. Med. 172 981-984.
55. A. Chow (1989) Microbiology of toxic shock syndrome: Overview. Rev. Infect. Dis. 1 55-60.
56. A.W. Chow, C.K. Wong, A.M. MacFarlane, et al. (1984) Toxic shock syndrome: Clinical and laboratory findings in 30 patients. Can. Med. Assoc. J. 130 425-430.
57. M.C. Chu, B.N. Kreiswirth, P.A. Pattee, et al. (1988) Association of toxic shock toxin-1 determinant with a heterologous insertion at multiple loci in the Staphylococcus aureus chromosome. Infect. Immun. 56 2702-2708.
58. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol—United States and Canada, 2001-2005. M. M. W. R. Morb. Mortal. Wkly. Rep. 54(20), 724.
59. K.R. Cohen, K.M. Emmons and M.F. Goldstein (1983) Naloxone treatment of toxic shock syndrome. Arch. Intern. Med. 143 1072.
60. R.P. Cole and P.G. Shakespeare (1990) Toxic-shock syndrome in scalded children. Burns 16 221-224.
61. L.A. Cone, D.R. Woodward, R.G. Byrd, et al. (1992) A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J. Infect. Dis. 165 638-643.
62. L.A. Cone, D.R. Woodard, P.M. Schlievert, et al. (1987) Clinical and bacteriologic observations of a toxic-shock–like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317 146-149.
63. E.E. Conway Jr., R.S. Haber, J. Gumprecht, et al. (1991) Toxic shock syndrome following influenza A in a child. Crit. Care Med. 19 123-125.
64. R.S. Cotran, J.S. Proba, M.A. Gimbrone, et al. (1987) Endothelial activation during IL-2 immunotherapy: A possible mechanism for the vascular leak syndrome. J. Immunol. 139 1883.
65. R.K. Cowan and M.G. Martens (1993) Toxic shock syndrome mimicking pelvic inflammatory disease presumably resulting from tattoo. South. Med. J. 86 1427-1431.
66. B.A. Crass and M.S. Bergdoll (1986) Toxin involvement in toxic shock syndrome. J. Infect. Dis. 153 918-926.
67. J.R. Crews, J.K. Harrison, G.R. Corey, et al. (1992) Stunned myocardium in the toxic shock syndrome. Ann. Intern. Med. 117 912-913.
68. W.E. Crowder and F.C. Shannon (1983) Colposcopic diagnosis of vaginal ulcerations in toxic-shock syndrome. Obstet. Gynecol. 61 505-535.
69. M.A. Crowther and E.D. Ralph (1993) Menstrual toxic shock syndrome complicated by persistent bacteremia: Case report and review. Clin. Infect. Dis. 16 288-289.
70. R.W. Danielson (1983) Vaginal ulcers caused by tampons. Am. J. Obstet. Gynecol. 146 547-549.
71. E.J. Dann, M. Weinberger, S. Gillis, et al. (1994) Bacterial laryngotracheitis associated with toxic-shock syndrome in an adult. Clin. Infect. Dis. 18 437-439.
72. J. Darenberg, N. Ihendyane, J. Sjolin, et al. (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37 333-340.
73. R.C. Dart and M.A. Levitt (1985) Toxic-shock syndrome associated with the use of the vaginal contraceptive sponge. J. A. M. A. 253 1877.
74. A.C. Davidson, M. Creach and I.R. Cameron (1990) Staphylococcal pneumonia, pneumatoceles, and the toxic shock syndrome. Thorax 45 639-640.
75. J.P. Davis, P.J. Chesney, P.J. Wand, et al. (1980) Toxic shock syndrome: Epidemiologic features, recurrences, risk factors and prevention. N. Engl. J. Med. 303 1429-1435.
76. J.P. Davis, M.T. Osterholm, C.M. Helms, et al. (1982) Tristate toxic-shock syndrome study. II. Clinical and laboratory findings. J. Infect. Dis. 145 441-448.
77. J.P. Davis and J.M. Vergeront (1982) The effect of publicity on the reporting of toxic-shock syndrome in Wisconsin. J. Infect. Dis. 145 449-457.
78. J.P. Davis and J.M. Vergeront (1982) A review of toxic shock syndrome surveillance in Wisconsin: The effect of media publicity and laboratory services on reporting of illness. Ann. Intern. Med. 96 883-886.
79. J.P. Davis, J.V. Vergeront, L.E. Amsterdam, et al. (1989) Long-term effects of TSS in women: Sequelae, subsequent pregnancy, menstrual history, and long-term trends in catamenial product use. Rev. Infect. Dis. 11(Suppl.), 50.
80. J.P. Davis, J.M. Vergeront and P.J. Chesney (1982) Possible host-defense mechanisms in toxic shock syndrome. Ann. Intern. Med. 96 986-991.
81. J.C.S. de Azavedo (1989) Animal models for toxic-shock syndrome: Overview. Rev. Infect. Dis. 11(Suppl.), 205-209.
82. J.C.S. de Azavedo, T.J. Foster, J. Hartigan, et al. (1985) Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model. Infect. Immun. 50 304-309.
83. M.L. De Boer and A.W. Chow (1994) Toxic shock syndrome toxin 1–producing Staphylococcus aureus isolates contain the staphylococcal enterotoxin B genetic element but do not express staphylococcal enterotoxin B. J. Infect. Dis. 170 818-827.
84. T.R. Deetz, R. Reves and E. Septimus (1981) Secondary rash in toxic shock syndrome. N. Engl. J. Med. 304 174.
85. R.L. Deresiewicz (1997) Staphylococcal toxic shock syndrome. D.Y.M. Leung, B.T. Huber, P.M. Schlievert (Eds) Superantigens: Molecular Biology, Immunology and Relevance to Human Disease New York: Marcel Dekker
86. DeVries, A., Leshser, L., and Lynfield, R.: Staphylococcal toxic shock syndrome, Minnesota, 2000-2003. Abstract 379. Presented at 44th Annual Meeting of the Infectious Diseases Society of America, San Francisco, October 2006, pp. 118.
87. N. deVries and S. Vander Baan (1989) Toxic shock syndrome after nasal surgery: Is prevention possible? A case report and review of literature. Rhinology 27 125-128.
88. N. Dickgiesser and U. Wallach (1987) Toxic shock syndrome toxin-1 (TSST-1): Influence of its production by subinhibitory antibiotic concentrations. Infection 15 351-353.
89. B.A. Diep, H.A. Carleton, R.F. Chang, et al. (2006) Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 193 1495-1503.
90. M.E. Donawa, G.R. Schmid and M.T. Osterholm (1984) Toxic shock syndrome: Chronology of state and federal epidemiologic studies and regulatory decision-making. Public Health Rep. 99 342-350.
91. A.M. Dondorp, J. Veenstra, T. vanderPoll, et al. (1994) Activation of the cytokine network in a patient with AIDS and the recalcitrant erythematous desquamating disorder. Clin. Infect. Dis. 18 942-945.
92. B.W. Donnelly, J.A. McMillan and L.B. Weiner (1990) Bacterial tracheitis: Report of eight new cases and a review. Rev. Infect. Dis. 12 729-735.
93. K.J. Dornan, D.M. Thompson, A.R. Conn, et al. (1982) Toxic shock syndrome in the postoperative patient. Surg. Gynecol. Obstet. 154 65-68.
94. C. Driessen, K. Hirv, H. Kirchner, et al. (1995) Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 84 272-277.
95. U.B. Dunnet and E.M. Schallibaum (1960) Scarlet fever–like illness due to staphylococcal infection. Lancet 2 1227-1229.
96. G. Durand, M. Bes, H. Meugnier, et al. (2006) Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J. Clin. Microbiol. 44 847-853.
97. H. Eagle (1952) Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am. J. Med. 13 389-399.
98. V. Edwards-Jones, M.M. Dawson and C. Childs (2000) A survey into toxic shock syndrome (TSS) in UK burn units. Burns 26 323-333.
99. V. Edwards-Jones and H.A. Foster (1994) The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1. J. Med. Microbiol. 41 408-413.
100. T. Ejlertsen and P.A. Porsborg (1994) Toxic-shock syndrome related to simultaneous Staphylococcus aureus epiglottic abscess and group A streptococcal pharyngitis with bacteremia. A. P. M. I. S. 102 956-959.
101. D.J. Elbaum, C. Wood, F. Abuabara, et al. (1984) Bullae in a patient with toxic shock syndrome. J. Am. Acad. Dermatol. 10 267-272.
102. D.D. Elsberry, D.A. Rhoda and W.R. Beisel (1969) Hemodynamics of staphylococcal B enterotoxemia and other types of shock in monkeys. J. Appl. Physiol. 27 164.
103. B. Eriksson, J. Anderson, A.M. Bergholm, et al. (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J. Infect. Dis. 180 410-418.
104. F. Espersen, L. Baek, P. Kjaeldgaard, et al. (1988) Detection of staphylococcal toxic shock syndrome toxin 1 by a latex agglutination kit. Scand. J. Infect. Dis. 20 449-450.
105. G. Faich, K. Pearson, D. Fleming, et al. (1986) Toxic-shock syndrome and the vaginal contraceptive sponge. J. A. M. A. 255 216-218.
106. D.E. Farley, V.L. Katz and D.J. Dotters (1993) Toxic shock syndrome associated with vulvar necrotizing fasciitis. Obstet. Gynecol. 82 660-662.
107. D.J. Fast, P.M. Schlievert and R.D. Nelson (1988) Nonpurulent response to toxic shock syndrome toxin-1–producing Staphylococcus aureus. J. Immunol. 140 949-953.
108. C.A. Feldman (1962) Staphylococcal scarlet fever. N. Engl. J. Med. 267 877-888.
109. M.A. Ferguson and J.K. Todd (1990) Toxic-shock syndrome associated with Staphylococcus aureus sinusitis in children. J. Infect. Dis. 161 953-955.
110. C.J. Fichtenbaum, L.R. Peterson and G.J. Weil (1993) Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am. J. Med. 95 351-357.
111. J.W. Finkelstein and A. von Eye (1990) Sanitary product use by white, black and Mexican American women. Public Health Rep. 105 491.
112. S. Finkelstein and R.H. Hyland (1993) Toxic shock syndrome as the AIDS defining diagnosis. Chest 104 950-951.
113. M. Fischer, J. Bhatnagar, J. Guarner, et al. (2005) Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N. Engl. J. Med. 353 2352-2360.
114. C.J. Fisher Jr., Z. Horowitz and T.E. Albertson (1985) Cardiorespiratory failure in toxic shock syndrome: Effect of dobutamine. Crit. Care Med. 13 160-165.
115. C.J. Fisher Jr., B.Z. Horowitz and S.M. Nolan (1981) The clinical spectrum of toxic shock syndrome. West. J. Med. 15 175-182.
116. R.F. Fisher, H.C. Goodpasture, J.D. Peterie, et al. (1981) Toxic shock syndrome in menstruating women. Ann. Intern. Med. 94 156-163.
117. J.D. Fitz, K.D. Weeks and P. Duff (1983) Left ventricular dysfunction in a patient with toxic shock syndrome. Am. J. Obstet. Gynecol. 146 467-468.
118. J.R. Fitzgerald, D.E. Sturdevant, S.M. Mackie, et al. (2001) Evolutionary genomics of Staphylococcus aureus: Insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc. Natl. Acad. Sci. U. S. A. 98 8821-8826.
119. D. Foley-Nolan, R.J. Coughlan and D. Sugrue (1989) Toxic shock syndrome associated arthropathy. Staphylococcus aureus: A further triggering event in reactive arthritis? Ann. Rheum. Dis. 48 331.
120. Follow-up on toxic-shock syndrome—United States. M. M. W. R. Morb. Mortal. Wkly. Rep. 29 441-445.
121. J.A. Fornadley, P.J. Gomez, R.T. Crane, et al. (1990) Toxic shock syndrome following submandibular gland excision. Head Neck 12 66-68.
122. J.D. Frame, M.D. Eve, M.E. Hackett, et al. (1985) The toxic shock syndrome in burned children. Burns 11 234-241.
123. R. Fuleihan, N. Trede, T. Chatila, et al. (1994) Superantigens activate HIV-1 gene expression in monocytic cells. Clin. Immunol. Immunopathol. 72 357-361.
124. P. Galea and K.M. Goel (1987) Toxic shock syndrome (TSS) in children. Scott. Med. J. 32 28-29.
125. P.G. Gallagher and C.M. Myer (1991) An approach to the diagnosis and treatment of membranous laryngotracheobronchitis in infants and children. Pediatr. Emerg. Care 7 337-342.
126. P.L. Garbe, R.J. Arko, A.L. Reingold, et al. (1985) Staphylococcus aureus isolates from patients with non-menstrual toxic shock syndrome: Evidence for additional toxins. J. A. M. A. 253 2538-2542.
127. S. Gaventa, A.L. Reingold, A.W. Hightower, et al. (1989) Active surveillance for TSS in the United States. Rev. Infect. Dis. 11(Suppl.), 28-34.
128. M.J. Glazowski, G.Z. Ostergaard, M. Arpi, et al. (1992) Toxic shock syndrome: A case of a child with burns. Ugeskr. Laeger 154 868-869.
129. I.B. Gosbell (2005) Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Intern. Med. J. 35(Suppl. 2), S120-S135.
130. G.R. Gourley, P.J. Chesney, J.P. Davis, et al. (1981) Acute cholestasis in patients with toxic-shock syndrome. Gastroenterology 81 928-931.
131. D.R. Graham, M. O'Brien, J.M. Hayes, et al. (1995) Postoperative toxic shock syndrome. Clin. Infect. Dis. 20 895-899.
132. S.P. Hackett and D.L. Stevens (1993) Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor β synthesis. J. Infect. Dis. 168 232-235.
133. R.A. Hajjeh, A. Reingold, A. Weil, et al. (1999) Toxic shock syndrome in the United States: Surveillance update, 1979-1996. Emerg. Infect. Dis. 5 807-810.
134. A.R.A. Hamad, P. Marrach and J.W. Kappler (1997) Transcytosis of staphylococcal superantigen toxins. J. Exp. Med. 185 1447-1454.
135. S.R. Hanafiah and S.K.F. Chong (1991) Toxic shock syndrome presenting as an acute encephalopathy and diarrhoea. J. R. Soc. Med. 84 48-49.
136. S. Hauschildt, W.G. Bessler and P. Scheipers (1993) Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow–derived macrophages. Eur. J. Immunol. 23 2988-2992.
137. J. Hayward, J.M. Vergeront, S.J. Stolz-LaVerriere, et al. (1986) A hospital discharge code review of toxic shock syndrome in Wisconsin. Am. J. Epidemiol. 123 876-883.
138. S.D. Helgerson and L.R. Foster (1982) Toxic shock syndrome in Oregon: Epidemiologic findings. Ann. Intern. Med. 96 909-911.
139. C.M. Helms, R.W. Lengeling, R.L. Pinsky, et al. (1981) Toxic shock syndrome: A retrospective study of 25 cases from Iowa. Am. J. Med. Sci. 282 50-60.
140. T. Hensler, M. Koller, C. Geoffroy, et al. (1993) Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils. Infect. Immun. 61 1055-1061.
141. H. Herwald, H. Cramer, M. Morgelin, et al. (2004) M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116 367-379.
142. A.J. Heywood and S. al-Essa (1990) Toxic shock syndrome in child with only 2% burn. Lancet 335 867.
143. K. Hiramatsu (2001) Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance. Lancet Infect. Dis. 1 147-155.
144. A. Hirose-Kumagai, F.H. Whipple, T. Ikejima, et al. (1984) A comparison of neutralizing and antigen-binding assays for human antibodies against toxic-shock-syndrome 1. J. Infect. Dis. 150 788.
145. J.M. Hurley, R. Shimonkevitz, A. Hanagan, et al. (1995) Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J. Exp. Med. 181 2229.
146. R.M. Hurwitz and A.B. Ackerman (1985) Cutaneous pathology of the toxic shock syndrome. Am. J. Dermatopathol. 7 563.
147. K. Kikuchi, N. Takahashi, C. Piao, et al. (2003) Molecular epidemiology of MRSA strains causing neonatal TSS-like exanthematous disease in neonatal and perinatal wards. J. Clin. Microbiol. 41 3001-3006.
148. J.J. Iandolo (1989) Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu. Rev. Microbiol. 43 375-402.
149. T. Ikejima and C.A. Dinarello (1985) Distribution of radiolabeled toxic shock syndrome toxin: Implications for the pathogenesis of interleukin-1–mediated toxic shock syndrome. J. Leukoc. Biol. 37 714.
150. K.G. Ishak and W.A. Rogers (1981) Cryptogenic acute cholangitis: Association with toxic shock syndrome. Am. J. Clin. Pathol. 76 619-626.
151. J.A. Jacobson, E.M. Kasworm, R.G. Bolte, et al. (1989) Prevalence of nasal carriage of toxigenic Staphylococcus aureus and antibody to TSST-1 in Utah children. Rev. Infect. Dis. 11(Suppl.), 324-325.
152. J.A. Jacobson, E. Kasworm and J.A. Daly (1989) Risk of developing TSS associated with TSST-1 following nongenital staphylococcal infection. Rev. Infect. Dis. 11(Suppl.), 8-13.
153. J.A. Jacobson, E.M. Kasworm, R.F. Reiser, et al. (1987) Low incidence of toxic shock syndrome in children with staphylococcal infection. Am. J. Med. Sci. 294 403-407.
154. J.A. Jacobson, M.H. Stevens and E.M. Kasworm (1988) Evaluation of single-dose cefazol in prophylaxis for toxic-shock syndrome. Arch. Otolaryngol. Head Neck Surg. 114 326-327.
155. R.C. James and C.J. MacLeod (1961) Induction of staphylococcal infections in mice with small inocula introduced on sutures. Br. J. Exp. Pathol. 42 266.
156. B. Jaulhac, M. Bes, N. Bornstein, et al. (1992) Synthetic DNA probes for detection of genes for enterotoxins A, B, C, D, E and for TSST-1 in staphylococcal strains. J. Appl. Bacteriol. 72 386-392.
157. W.M. Johnson, S.D. Tyler, E.P. Ewan, et al. (1991) Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J. Clin. Microbiol. 29 426-430.
158. K.C. Kain, M. Schulzer and A.W. Chow (1993) Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): Comparison with menstrual TSS by multivariate discriminant analyses. Clin. Infect. Dis. 16 100-106.
159. N.S. Kamel, M.C. Banks, A. Dosik, et al. (2002) Lack of mucocutaneous signs of toxic shock syndrome when T cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma. Clin. Exp. Immunol. 128 131-139.
160. J. Kappler, B. Kotzin, L. Herron, et al. (1989) Vβ-specific stimulation of human T-cells by staphylococcal toxins. Science 244 811-813.
161. K. Kato and T. Tanaka (1992) MRSA infection and toxic shock syndrome in burn patients. Jpn. J. Clin. Med. 50 1104-1111.
162. M.W. Kehrberg, R.H. Latham, B.T. Haslam, et al. (1981) Risk factors for staphylococcal toxic-shock syndrome. Am. J. Epidemiol. 114 873-879.
163. D.S. Kernodle, P.A. McGraw, N.L. Barg, et al. (1995) Growth of Staphylococcus aureus with nafcillin in vitro induces α-toxin production and increases the lethal activity of sterile broth filtrates in a murine model. J. Infect. Dis. 172 410-419.
164. M.W. Kline and L.M. Dunkle (1988) Toxic shock syndrome and the acquired immunodeficiency syndrome. Pediatr. Infect. Dis. J. 7 736-738.
165. D. Kotasek, G.M. Vercelloti, A.C. Ochoa, et al. (1988) Mechanism of cultured endothelial injury induced by lymphokine activated killer cells. Cancer Res. 48 5528.
166. M. Kotb (1995) Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8 411-426.
167. T. Krakauer (1995) Inhibition of toxic shock syndrome toxin-1–induced cytokine production and T cell activation by interleukin-10, interleukin-4 and dexamethasone. J. Infect. Dis. 172 988-992.
168. G.R. Kravitz, D.J. Dries, M.L. Peterson, et al. (2005) Purpura fulminans due to Staphylococcus aureus. Clin. Infect. Dis. 40 941-947.
169. B.N. Kreiswirth, G.R. Kravitz, P.M. Schlievert, et al. (1986) Nosocomial transmission of a strain of Staphylococcus aureus causing toxic shock syndrome. Ann. Intern. Med. 105 704.
170. B.N. Kreiswirth, S.J. Projan, P.M. Schlievert, et al. (1989) Toxic shock syndrome toxin 1 is encoded by a variable genetic element. Rev. Infect. Dis. 11(Suppl.), 83-88.
171. W.W.S. Ku and A.W. Chow (1996) Monoclonal antibodies (MAb5 and MAb4) protect against the lethal effect of toxic shock syndrome toxin-1 in the d-galactosamine sensitized mouse mode. Abstract. J. Invest. Med. 110 68.
172. W.W. Kum and A.W. Chow (2001) Inhibition of staphylococcal enterotoxin A–induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. J. Infect. Dis. 183 1739-1748.
173. V.M. Kushnaryov, H.S. MacDonald, R.F. Reiser, et al. (1989) Reaction of TSST-1 with endothelium of human umbilical cord vein. Rev. Infect. Dis. 11(Suppl.), 282-287.
174. S.M. Larkin, D.N. Williams, M.T. Osterholm, et al. (1982) Toxic shock syndrome: Clinical, laboratory, and pathologic findings in nine fatal cases. Ann. Intern. Med. 96 858-864.
175. R.H. Latham, M.W. Kehrberg, J.A. Jacobson, et al. (1982) Toxic shock syndrome in Utah: A case-control and surveillance study. Ann. Intern. Med. 96 906-908.
176. P.K. Lee, G.M. Vercellotti, J.R. Deringer, et al. (1991) Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J. Infect. Dis. 164 711-719.
177. V.T.P. Lee, A.H. Chang and A.W. Chow (1992) Detection of staphylococcal enterotoxin B among toxic-shock syndrome (TSS) and non-TSS associated Staphylococcus aureus isolates. J. Infect. Dis. 166 911-915.
178. A. Lovseth, S. Loncarevic, K.G. Berdal, et al. (2004) Modified multiplex PCR method for detection of pyrogenic exotoxin genes in staphylococcal isolates. J. Clin. Microbiol. 42 3869-3872.
179. L. Lund, D. Nielsen and E.S. Anderson (1988) Meningismus as the main symptom in toxic shock syndrome. Acta Obstet. Gynecol. Scand. 67 395.
180. K.L. MacDonald, M.T. Osterholm, C.W. Hedberg, et al. (1987) Toxic shock syndrome: A newly recognized complication of influenza and influenza like illness. J. A. M. A. 257 1053-1058.
181. U. Malknecht, M. Hunter, M.K. Hoffmann, et al. (1996) The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo. Hum. Immunol. 45 42-45.
182. Marlowe, D. E., Weigle, R. M., and Stauffenberg, R. S.: Measurement of Tampon Absorbency: Evaluation of Tampon Brands. Rockville, MD, FDA Bureau of Biologics, 1981.
183. L. Marodi, R. Kaposzta, F. Rozgonyi, et al. (1995) Staphylococcal enterotoxin A involvement in the illness of a 20-month-old burn patient. Pediatr. Infect. Dis. J. 14 632-634.
184. R.R. Marples and A.A. Wienecke (1993) Enterotoxins and toxic-shock syndrome-1 in non-enteric staphylococcal disease. Epidemiol. Infect. 110 477-488.
185. P. Marrack and J. Kappler (1990) The staphylococcal enterotoxins and their relatives. Science 248 705-711.
186. R.R. Martin, V. Buttram, P. Besch, et al. (1982) Nasal and vaginal Staphylococcus aureus in young women: Quantitative studies. Ann. Intern. Med. 96 951-953.
187. Y. Matsuda, H. Kato, R. Yamada, et al. (2003) Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor Vβ2-positive T cells. Emerg. Infect. Dis. 9 387-389.
188. R.M. McAllister, N.S. Mercer, B.D. Morgan, et al. (1993) Early diagnosis of staphylococcal toxemia in burned children. Burns 19 22-25.
189. J.K. McCormick, J.M. Yarwood and P.M. Schlievert (2001) Toxic shock syndrome and bacterial superantigens: An update. Annu. Rev. Microbiol. 55 77-104.
190. V.G. McGann, J.B. Rollins and D.W. Mason (1971) Evaluation of resistance to staphylococcal enterotoxin B: Naturally acquired antibodies of man and monkey. J. Infect. Dis. 124 206-213.
191. M.E. McIvor and M.L. Levin (1982) Treatment of recurrent toxic shock syndrome with oral contraceptive agents. Md. Med. J. 31 56-57.
192. U.G. McKenna, J.A. Meadows III, N.S. Brewer, et al. (1980) Toxic shock syndrome, a newly recognized disease entity: Report of 11 cases. Mayo Clin. Proc. 55 663-672.
193. W.S. McMahon, M.E. Patrenos, M.E. McConnell, et al. (1990) Complete heart block in toxic shock syndrome. Am. J. Dis. Child. 144 748.
194. M. Mehrotra, G. Wang, W.M. Johnson, et al. (2000) Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J. Clin. Microbiol. 38 1032-1035.
195. M.E. Melish, F.S. Chen and M.S. Murata (1983) Quantitative detection of toxic shock marker protein in human and experimental toxic shock syndrome. Abstract. Clin. Res. 31 122.
196. M.E. Melish, K.S. Frogner, S.A. Hirata, et al. (1987) Use of IVGG for therapy in the rabbit model of TSS. Abstract. Clin. Res. 35 220.
197. M.E. Melish, S. Murata, C. Fukunaga, et al. (1988) Corticosteroid and immunoglobulin therapy in toxic shock syndrome (TSS). Abstract. Clin. Res. 36 781.
198. M.E. Melish, S. Murata, C. Fukunaga, et al. (1989) Endotoxin is not an essential mediator in TSS. Rev. Infect. Dis. 11(Suppl.), 219-228.
199. M.E. Melish, S. Murata, C. Fukunaga, et al. (1989) Vaginal tampon model for toxic shock syndrome. Rev. Infect. Dis. 11(Suppl.), 238-246.
200. M.E. Melish, S. Murata, C. Fukunaga, et al. (1989) Corticosteroid and immunoglobulin therapy in TSS. Rev. Infect. Dis. 11(Suppl.), 332-333.
201. T.C. Michels (1986) Mucocutaneous lymph node syndrome in adults: Differentiation from toxic shock syndrome. Am. J. Med. 80 724.
202. C.A. Michie, T. Davis and M. MacAllister (1996) The sequelae of toxic shock syndrome. Abstract. Pediatr. Res. 39 179.
203. T. Miethke, K. Duschek, C. Wahl, et al. (1993) Pathogenesis of the toxic shock syndrome: T-cell–mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 23 1494-1500.
204. T. Miethke, I.C. Wahl, K. Heeg, et al. (1992) T-cell–mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J. Exp. Med. 175 91-98.
205. T. Miethke, C. Wahl, D. Regele, et al. (1993) Staphylococcus aureus mediated shock: A cytokine release syndrome. Immunobiology 189 270-284.
206. S.D. Miller (1994) Postoperative toxic shock syndrome after lumbar laminectomy in a male patient. Spine 19 1182-1185.
207. W. Miller and J.A. Stankiewicz (1994) Delayed toxic shock syndrome in sinus surgery. Otolaryngol. Head Neck Surg. 111 121-123.
208. J.T. Mills, J. Parsonnet, R.K. Hickman, et al. (1985) Control of production of toxic-shock syndrome toxin-1 (TSST-1) by magnesium ion. J. Infect. Dis. 151 1158-1161.
209. K. Miwa, M. Fukuyama, T. Kunitomo, et al. (1994) Rapid assay for detection of toxic shock syndrome toxin 1 from human sera. J. Clin. Microbiol. 32 539-542.
210. S.B. Mohan, A. Tamilarasan and M. Buhl (1994) Inhalational mercury poisoning masquerading as toxic shock syndrome. Anaesth. Intensive Care 22 305-306.
211. M. Mohsenipour, E. Deusch, K. Twerdy, et al. (1994) Toxic shock syndrome in transsphenoidal neurosurgery. Acta Neurochir. 128 169-170.
212. M.A. Moyer, L.D. Edwards and M.S. Bergdoll (1983) Nosocomial toxic shock syndrome in two patients after knee surgery. Am. J. Infect. Control 11 83-87.
213. D.L. Murray, C.A. Earhart, D.T. Mitchell, et al. (1996) Localization of biologically important regions on toxic shock syndrome toxin-1. Infect. Immun. 64 371-374.
214. J.M. Musser, P.M. Schlievert, A.W. Chow, et al. (1990) A single clone of Staphylococcus aureus causes the majority of cases of toxic-shock syndrome. Proc. Natl. Acad. Sci. U. S. A. 87 225-229.
215. D. Nadal, R.P. Lauener, C.P. Braegger, et al. (1993) T-cell activation and cytokine release in streptococcal toxic shock–like syndrome. J. Pediatr. 122 727-729.
216. R.J. Neill, G.R. Fanning, F. Delahoz, et al. (1990) Oligonucleotide probes for detection and differentiation of Staphylococcus aureus strains containing genes for enterotoxins A, B, and C and toxic shock syndrome toxin 1. J. Clin. Microbiol. 28 1514-1518.
217. S.L. Nightingale (1990) New requirements for tampon labeling. Am. Fam. Physician 41 999.
218. C. Nijssen-Jordan, J.D. Donaldson and S.A. Halperin (1990) Bacterial tracheitis associated with respiratory syncytial virus infection and toxic-shock syndrome. Can. Med. Assoc. J. 142 233-234.
219. J. Nishi, M. Yoshinaga, H. Miyanohara, et al. (2002) An epidemiologic survey of methicillin-resistant Staphylococcus aureus by combined use of mec-HVR genotyping and toxin genotyping in a university hospital in Japan. Infect. Control Hosp. Epidemiol. 23 506-510.
220. A. Norrby-Teglund, K. Pauksens, S.E. Holm, et al. (1994) Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect. Dis. 170 585-591.
221. M. Ogawa, S. Ueda, N. Anzai, et al. (1995) Toxic shock syndrome after staphylococcal pneumonia treated with intravenous immunoglobulin. Vox Sang. 68 59-60.
222. O'Gilvie vs. International Playtex, No. 83-1845, Vol. 37 (DC Kansas March 21, 1985, post-trial motions and court findings).
223. L.L. Olesen, T. Ejlertsen and J. Nielsen (1991) Toxic shock syndrome following insertion of breast prostheses. Br. J. Surg. 78 585-586.
224. R.D. Olson, D.L. Stevens and M.E. Melish (1989) Direct effects of purified staphylococcal TSST-1 on myocardial function of isolated rabbit atria. Rev. Infect. Dis. 11(Suppl.), 313-315.
225. A.B. Onderdonk, M.L. Delaney, G.R. Zamarchi, et al. (1989) Normal vaginal microflora during use of various forms of catamenial protection. Rev. Infect. Dis. 11(Suppl.), 61-67.
226. J.A. Orden, J. Goyache, F.J. Hernandez, et al. (1991) Detection of staphylococcal enterotoxin and toxic shock syndrome toxin-1 (TSST-1) by immunoblot combined with a semiautomated electrophoresis system. J. Immunol. Methods 144 197-202.
227. M.T. Osterholm, J.P. Davis, R.W. Gibson, et al. (1982) Tri-state toxic-shock syndrome study. I. Epidemiologic findings. J. Infect. Dis. 145 431-440.
228. M.T. Osterholm, J.P. Davis, R.W. Gibson, et al. (1982) Toxic shock syndrome: Relation to catamenial products, personal health and hygiene, and sexual practices. Ann. Intern. Med. 96 954-958.
229. M.T. Osterholm and J.C. Forfang (1982) Toxic-shock syndrome in Minnesota: Results of an active-passive surveillance system. J. Infect. Dis. 145 458-464.
230. A.L. Paris, L.A. Herwaldt, D. Blum, et al. (1982) Pathologic findings in twelve fatal cases of toxic-shock syndrome. Ann. Intern. Med. 96 852-857.
231. D.E. Parkin (1995) Fatal toxic shock syndrome following endometrial resection. Br. J. Obstet. Gynaecol. 102 163-164.
232. J. Parsonnet (1989) Mediators in the pathogenesis of TSS: Overview. Rev. Infect. Dis. 11(Suppl.), 263-269.
233. J. Parsonnet (1996) Nonmenstrual toxic shock syndrome: New insights into diagnosis, pathogenesis and treatment. Curr. Clin. Top. Infect. Dis. 16 1-20.
234. J. Parsonnet, Z.A. Gillis and G.B. Pier (1986) Induction of interleukin-1 by strains of Staphylococcus aureus from patients with non-menstrual toxic shock syndrome. J. Infect. Dis. 154 55-63.
235. J. Parsonnet, Z.A. Gillis, M.R. Thompson, et al. (1989) Effects of monoclonal antibody on biologic function of TSST-1 in vitro and in vivo. Rev. Infect. Dis. 11(Suppl.), 318-319.
236. J. Parsonnet, M.A. Hansmann, M.L. Delaney, et al. (2005) Prevalence of toxic shock syndrome toxin 1–producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 43 4628-4634.
237. Parsonnet, J., Modern, P. A., and Giacobbe, K.: Effect of subinhibitory concentrations of antibiotics on production of toxic shock syndrome toxin-1 (TSST-1). Abstract 29. Presented at the 32nd Annual Meeting of the Infectious Diseases Society of America, 1994, Washington, DC.
238. J. Parsonnet, P.A. Modern and K.D. Giacobbe (1996) Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro. J. Infect. Dis. 173 98-103.
239. Parsonnet, J., Tosteson, A., Modern, P., et al.: Antibody to toxic shock syndrome toxin-1 (TSST-1) and vaginal colonization by TSST-1 producing S. aureus among adolescent women. Abstract 1327. Presented at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 1993, Washington, DC.
240. M.P. Paterson, E.B. Hoffman and P. Roux (1990) Severe disseminated staphylococcal disease associated with osteitis and septic arthritis. J. Bone Joint Surg. Br. 72 94-97.
241. D.B. Petitti, A. Reingold and J. Chin (1986) The incidence of toxic shock syndrome in northern California: 1972 through 1983. J. A. M. A. 255 368-372.
242. R. Pokriefka, M. Rabah, L. Saravolatz, et al. (1994) Toxic shock syndrome in an injection drug user with Staphylococcus aureus endocarditis. Infect. Med. 11 34-36. 48-49
243. T. Potter, F. DiGregorio, M. Stiff, et al. (1994) Dilantin hypersensitivity syndrome imitating staphylococcal toxic shock. Arch. Dermatol. 130 856-858.
244. Prevention and Recognition of TSS (1982) Institute of Medicine: Toxic Shock Syndrome: Assessment of Current Information and Future Research Needs Washington, DC: National Academy Press 85-86.
245. S.J. Projan, S. Brown-Skrobot and P.M. Schlievert (1994) Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J. Bacteriol. 176 4204-4209.
246. M.G. Raab, M. O'Brien, J.M. Hayes, et al. (1995) Postoperative toxic shock syndrome. Am. J. Orthop. 24 130-136.
247. J.K. Rasheed, R.J. Arko, J.C. Feeley, et al. (1985) Acquired ability of Staphylococcus aureus to produce toxic shock–associated protein and resulting illness in a rabbit model. Infect. Immun. 47 598-604.
248. Reduced incidence of menstrual toxic-shock syndrome—United States, 1980-1990. M. M. W. R. Morb. Mortal. Wkly. Rep. 39(25), 421-423.
249. A.L. Reingold (1984) Epidemiology of toxic-shock syndrome, United States, 1960-1984. M. M. W. R. C. D. C. Surveill. Summ. 33(3), 19SS-22SS.
250. A.L. Reingold, N.T. Hargrett, B.B. Dan, et al. (1982) Nonmenstrual toxic shock syndrome: A review of 130 cases. Ann. Intern. Med. 96 871-874.
251. K. Ren, J.D. Bannan, V. Pancholi, et al. (1994) Characterization and biological properties of a new staphylococcal exotoxin. J. Exp. Med. 180 1675-1683.
252. C.A. Rhee, R.J. Smith and I.T. Jackson (1994) Toxic shock syndrome associated with suction-assisted lipectomy. Aesthetic Plast. Surg. 18 161-163.
253. R.R. Rich (1993) Intravenous IgG: Supertherapy for superantigens. J. Clin. Invest. 91 378.
254. H.L. Ritz, J.J. Kirkland, G.G. Bond, et al. (1984) Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen–producing strains of Staphylococcus aureus. Infect. Immun. 43 954-958.
255. R.D. Rolston, S.M. Yabek, A.L. Florman, et al. (1990) Severe cardiac conduction abnormalities associated with atypical toxic-shock syndrome. J. Pediatr. 117 89.
256. F. Romagne, L. Besnardeau and B. Malissen (1992) A versatile method to produce antibodies to human T cell receptor V beta segments: Frequency determination of human V beta 2 − T cells that react with toxic-shock syndrome toxin-1. Eur. J. Immunol. 22 2749-2752.
257. P.G. Rose and G. Wilson (1994) Advanced cervical carcinoma presenting with toxic shock syndrome. Gynecol. Oncol. 52 264-266.
258. K.A. Rosene, M.K. Copass, L.S. Kastner, et al. (1982) Persistent neuropsychological sequelae of toxic shock syndrome. Ann. Intern. Med. 96 865-870.
259. P.M. Rosten, K.H. Bartlett and A.W. Chow (1988) Serologic responses to toxic shock syndrome (TSS) toxin-1 in menstrual and nonmenstrual TSS. Clin. Invest. Med. 11 187-192.
260. R.A. Rovner, R.A. Baird and M.M. Malerich (1984) Fatal toxic-shock syndrome as a complication of orthopedic surgery. J. Bone Joint Surg. Am. 66 952-954.
261. J.A. Royall, R.L. Berkow, J.S. Beckman, et al. (1989) Tumor necrosis factor and interleukin 1α increase vascular endothelial cell permeability. Am. J. Physiol. 257 L399-L410.
262. A.L. Sahs, C.M. Helms and C. DuBois (1983) Carpal tunnel syndrome: Complication of toxic shock syndrome. Arch. Neurol. 40 414-415.
263. J.H. Sales, K.S. Kennedy, P.T. Galantich, et al. (1991) Toxic shock syndrome associated with pharyngitis and submandibular space abscess. Ann. Otol. Rhinol. Laryngol. 100 540-543.
264. W.F. Schlech III, K.N. Shands, A.L. Reingold, et al. (1982) Risk factors for development of toxic shock syndrome: Association with a tampon brand. J. A. M. A. 7 835-839.
265. P.M. Schlievert (1982) Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect. Immun. 36 123-128.
266. P.M. Schlievert (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1 1149.
267. P.M. Schlievert (1995) Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. J. Infect. Dis. 172 1112-1114.
268. P.M. Schlievert, J.R. Deringer, M.H. Kim, et al. (1992) Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36 626-632.
269. P.M. Schlievert and J.A. Kelly (1984) Clindamycin-induced suppression of toxic-shock syndrome–associated exotoxin production. J. Infect. Dis. 149 471.
270. P.M. Schlievert, K.N. Shands, B.B. Dan, et al. (1981) Identification and characterization of exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J. Infect. Dis. 143 509-516.
271. P.M. Schlievert, T.J. Tripp and M.L. Peterson (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis–St. Paul, Minnesota, during the 2000-2003 surveillance period. J. Clin. Microbiol. 42 2875-2876.
272. F.J. Schmitz, C.R. Mackenzie, R. Geisel, et al. (1997) Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur. J. Epidemiol. 13 699-708.
273. F.J. Schmitz, M. Steiert, B. Hofmann, et al. (1998) Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates. J. Med. Microbiol. 47 335-340.
274. A. Schuchat and C.V. Broome (1991) Toxic shock syndrome and tampons. Epidemiol. Rev. 13 99-112.
275. B. Schwartz, S. Gaventa, C.V. Broome, et al. (1989) Nonmenstrual TSS associated with barrier contraceptives: Report of a case-control study. Rev. Infect. Dis. 11(Suppl.), 43-48.
276. D.F. Scott, G.K. Best, J.M. Kling, et al. (1989) Passive protection of rabbits infected with TSS associated strains of Staphylococcus aureus by monoclonal antibody to TSST-1. Rev. Infect. Dis. 11(Suppl.), 214-217.
277. K.N. Shands, G.P. Schmid, B.B. Dan, et al. (1980) Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303 1436-1442.
278. E. Shlasko, M.T. Harris, E. Benjamin, et al. (1991) Toxic shock syndrome after pilonidal cystectomy: Report of a case. Dis. Colon Rectum 34 502-505.
279. C. Sinave, G. Le Templier, D. Blouin, et al. (2002) Toxic shock syndrome due to Clostridium sordellii: A dramatic postpartum and postabortion disease. Clin. Infect. Dis. 35 1441-1443.
280. J.G. Sissons (1993) Superantigens and infectious disease. Lancet 341 1627-1629.
281. U. Skansen-Saphir, J. Andersson, L. Bjork, et al. (1994) Lymphokine production induced by streptococcal pyrogenic exotoxin A is selectively down regulated by pooled human IgG. Eur. J. Immunol. 24 916-922.
282. C.L. Slingluff Jr., W.W. Burns and C. Cooperberg (1990) Toxic shock syndrome after inguinal hernia repair: Report of a case with patient survival. Am. Surg. 56 610-612.
283. D.B. Smith and J. Gulinson (1988) Fatal cerebral edema complicating toxic shock syndrome. Neurosurgery 22 598-599.
284. J. Sparano and E. Ferranti (1986) The acquired immunodeficiency syndrome and non-menstrual toxic shock syndrome. Ann. Intern. Med. 105 300-301.
285. P.W. Spearman and W.J. Barson (1992) Toxic shock syndrome occurring in children with abrasive injuries beneath casts. J. Pediatr. Orthop. 12 169-172.
286. S.J. Sperber, D.D. Blevins and J.B. Francis (1990) Hypercalcitonemia, hypocalcemia, and toxic-shock syndrome. Rev. Infect. Dis. 12 736-739.
287. F. Spertini, H. Spits and R.S. Geha (1991) Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. U. S. A. 88 7533-7537.
288. Staphylococcus aureus resistant to vancomycin—United States, 2002. M. M. W. R. Morb. Mortal. Wkly. Rep. 51(26), 565-567.
289. D.L. Stevens, A.E. Gibbons, R. Bergstrom, et al. (1988) The eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J. Infect. Dis. 158 23-28.
290. D.L. Stevens, M.H. Tanner, J. Winship, et al. (1989) Severe group A streptococcal infections associated with a toxic shock–like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321 1-7.
291. D.L. Stevens, R.J. Wallace, S.M. Hamilton, et al. (2006) Successful treatment of staphylococcal toxic shock syndrome with linezolid: A case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin. Infect. Dis. 42 729-730.
292. D.L. Stevens, S. Yan and A.E. Bryant (1993) Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: An explanation for the inoculum effect. J. Infect. Dis. 167 1401-1405.
293. F.A. Stevens (1927) The occurrence of Staphylococcus aureus infection with a scarlatiniform rash. J. A. M. A. 18 1957-1958.
294. S.J. Stolz, J.P. Davis, J.M. Vergeront, et al. (1985) Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J. Infect. Dis. 151 883-889.
295. Y.C. Su and A.C. Wong (1995) Identification and purification of a new staphylococcal enterotoxin, H. Appl. Environ. Microbiol. 61 1438-1443.
296. Summary of notifiable diseases, United States, 1994. M. M. W. R. Morb. Mortal. Wkly. Rep. 43(53), 1-80.
297. J.D. Swift, M.C. Barruga, R.M. Perkin, et al. (1993) Respiratory failure complicating rubeola. Chest 104 1786-1787.
298. N. Takahashi, H. Kato, K. Imanishi, et al. (2000) Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J. Clin. Invest. 106 1409-1415.
299. N. Takahashi, H. Nishida, H. Kato, et al. (1998) Exanthematous disease induced by toxic shock syndrome toxin I in the early neonatal period. Lancet 351 1614-1619.
300. S. Takei, Y.K. Arora and S.M. Walker (1993) Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest. 91 602-607.
301. Tampon packages carry TSS information. F. D. A. Drug Bull. 3(3), 19-20.
302. T.D. Thompson and A.L. Friedman (1994) Simultaneous occurrence of Staphylococcus aureus–associated septic arthritis and toxic shock syndrome. Clin. Pediatr. (Phila.) 33 243-245.
303. P.M. Tierno Jr. and B.A. Hanna (1994) Propensity of tampons and barrier contraceptives to amplify Staphylococcus aureus toxic shock syndrome toxin-1. Infect. Dis. Obstet. Gynecol. 2 140-145.
304. J.K. Todd (1990) Therapy of toxic shock syndrome. Drugs 39 856-861.
305. J.K. Todd, M. Fishaut, F. Kapral, et al. (1978) Toxic-shock syndrome associated with phage-group-1 staphylococci. Lancet 2 1116-1118.
306. J.K. Todd, A. Franco-Buff, D.W. Lawellin, et al. (1984) Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect. Immun. 45 339-344.
307. J.K. Todd, M. Ressman, S.A. Caston, et al. (1984) Corticosteroid therapy for patients with toxic shock syndrome. J. A. M. A. 252 3399-3402.
308. J.K. Todd, B.H. Todd, A. Franco-Buff, et al. (1987) Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J. Infect. Dis. 155 673-681.
309. J.K. Todd, A.M. Weisenthal, M. Ressman, et al. (1985) Toxic shock syndrome. II. Estimated occurrence in Colorado as influenced by case ascertainment methods. Am. J. Epidemiol. 22 857-867.
310. R.W. Tofte and D.N. Williams (1981) Toxic shock syndrome: Evidence of a broad clinical spectrum. J. A. M. A. 246 2163-2167.
311. R.W. Tofte and D.N. Williams (1982) Clinical and laboratory manifestations of toxic shock syndrome. Ann. Intern. Med. 96 843-847.
312. R.W. Tolan Jr. (1993) Toxic shock syndrome complicating influenza A in a child: Case report and review. Clin. Infect. Dis. 17 43-45.
313. Toxic-shock syndrome and the vaginal contraceptive sponge. M. M. W. R. Morb. Mortal. Wkly. Rep. 33(4), 43-44. 49
314. Toxic shock syndrome following influenza—Oregon, United States; update on influenza activity—United States. M. M. W. R. Morb. Mortal. Wkly. Rep. 36(5), 64-65.
315. Toxic-shock syndrome—United States. M. M. W. R. Morb. Mortal. Wkly. Rep. 29 229-230.
316. Toxic-shock syndrome—United States, 1970-1980. M. M. W. R. Morb. Mortal. Wkly. Rep. 30(3), 25-28. 33
317. Toxic-shock syndrome, United States, 1970-1982. M. M. W. R. Morb. Mortal. Wkly. Rep. 31(16), 201-204.
318. K.J. Tracey, S.F. Lowry, B. Beutler, et al. (1986) Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J. Exp. Med. 164 1368-1373.
319. R. Turker, J.P. Lubicky and L.C. Vogel (1992) Toxic shock syndrome in patients with external fixators. J. Pediatr. Orthop. 12 658-662.
320. Update (1983) Toxic shock syndrome—United States. M. M. W. R. Morb. Mortal. Wkly. Rep. 32(30), 398-400.
321. N. Van der Mee-Marquet, G. Lina, R. Quentin, et al. (2003) Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: An alert for neonatologists. J. Clin. Microbiol. 41 4883-4884.
322. Vergeront, J. M., Blouse, L. E., Crass, B. A., et al.: Regional differences in the prevalence of serum antibody to toxic-shock toxin (anti-TST). Abstract 610. Presented at the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1984, Atlanta, p. 193.
323. J.M. Vergeront, M.L. Evenson, B.A. Crass, et al. (1982) Recovery of staphylococcal enterotoxin F from the breast milk of a woman with toxic-shock syndrome. J. Infect. Dis. 146 456-459.
324. J.M. Vergeront, S.J. Stolz, B.A. Crass, et al. (1983) Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: Implications for toxic shock syndrome. J. Infect. Dis. 148 692-698.
325. M.P. Vic-Dupont, P. Duval and S.R. Kamaliv (1965) Scarlatiniform staphylococcal diseases. Soc. Med. Hop. Paris 116 51.
326. G. Wagner, L. Bohr, P. Wagner, et al. (1984) Tampon-induced changes in vaginal oxygen and carbon dioxide tensions. Am. J. Obstet. Gynecol. 148 147-150.
327. R. Watanabe-Ohnishi, D.E. Low, A. McGeer, et al. (1995) Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J. Infect. Dis. 171 74-84.
328. J. Weinzweig, L.J. Gottlich and T.J. Krizek (1994) Toxic shock syndrome associated with the use of Biobrane in a scald burn victim. Burns 20 180-181.
329. S.M. Weissberg and M.G. Dodson (1983) Recurrent vaginal and cervical ulcers associated with tampon use. J. A. M. A. 250 1430-1431.
330. M. Wharton, T.L. Chorba, R.L. Vogt, et al. (1990) Case definitions for public health surveillance. M. M. W. R. Recomm. Rep. 39(RR-13), 1-43.
331. M. Whitby, S. Fraser, C.G. Gemmell, et al. (1983) Toxic shock syndrome and endocarditis. B. M. J. 286 1613.
332. J.L. Whiting, P.M. Rosten and A.W. Chow (1989) Determination by Western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non–TSS-associated Staphylococcus aureus. Infect. Immun. 57 231-234.
333. M.R. Wick, R.C. Bahn and U.G. McKenna (1982) Toxic shock syndrome: A fatal case with autopsy findings. Mayo Clin. Proc. 57 583-589.
334. A.M. Wiesenthal and J.K. Todd (1984) Toxic shock syndrome in children aged 10 years or less. Pediatrics 74 112-117.
335. A.C.L. Wong and M.S. Bergdoll (1990) Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect. Immun. 58 1026-1029.
336. Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. The Working Group on Severe Streptococcal infections. J. A. M. A. 269 390-391.
337. M. Yagoob, P. McClelland, A.E. Murray, et al. (1990) Staphylococcal enterotoxins A and C causing toxic shock syndrome. J. Infect. 20 176-178.
338. J.M. Yong (1994) Necrotising fasciitis. Lancet 343 1427.
339. R.T. Younis, C.W. Gross and R.H. Lazar (1991) Toxic shock syndrome following functional endonasal sinus surgery: A case report. Head Neck 13 247-248.
340. A. Zembowicz and J.R. Vane (1992) Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line. Proc. Natl. Acad. Sci. U. S. A. 89 2051-2055.
341. A. Zumla (1992) Superantigens, T cells and microbes. Clin. Infect. Dis. 15 313-320.